GENinCode (LON:GENI) Stock Price Down 9% – Time to Sell?

GENinCode Plc (LON:GENI)’s stock price dropped 9% on Wednesday . The company traded as low as GBX 1 and last traded at GBX 1.05. Approximately 13,474,982 shares traded hands during mid-day trading, an increase of 185% from the average daily volume of 4,730,915 shares. The stock had previously closed at GBX 1.15.

GENinCode Stock Performance

The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28. The stock has a market cap of £3.11 million, a price-to-earnings ratio of -0.46 and a beta of 0.66. The stock’s fifty day moving average is GBX 1.88 and its 200-day moving average is GBX 2.35.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.